Pens and prospering as a manufacturer

Trajan has been developing a world-first blood sampling device for several years. Brent Balinski spoke to company founder and chairman Stephen Tomisich about the hemaPEN – which is about to gain registration here and overseas – and where Australian companies can be competitive.

Bionomics receives huge R&D tax refund

Biopharmaceutical developer Bionomics (ASX: BNO) has received a $5.2 million R&D Tax Incentive Refund for 2018/2019 recognising its intense product development efforts. The company, which is developing a number of novel drug candidates based its unique ionX platform technology, appears to have received one of the largest refunds for the year. While most young drug…

Cochlear builds in China, develops new implant

Bionic ear manufacturer Cochlear (ASX: COH) is pressing ahead building a new factory in China and moving to human trials of a breakthrough new fully implantable cochlear device. Chairman Rick Holliday-Smith told Cochlear’s annual general meeting that ‘sound’ progress had been made developing its new Chinese manufacturing facility in Chengdu (pictured). He said the project…

Noxopharm reports anti-cancer effects of Veyonda

Sydney anti-cancer treatment company Noxopharm (ASX: NOX) has reported anti-cancer effects of its Veyonda treatment in a small group of patients suffering advanced prostate cancer. The 14 patients’ cancers were metastatic and they had exhausted all treatment options when given Veyonda in association with low-dosage radiation in a single lesion. After six months, cancer progression…

LBT Innovations makes its first instrument sale in the EU

Medical technology and equipment developer LBT Innovations (ASX: LBT) has made its first European sale of its APAS Independence laboratory instrument (pictured). The sale was made to one of the largest clinical laboratories in the EU, Labor Dr Wisplinghoff, which employes more than 40 medical specialists. Laboratory director Professor Hilmar Wilplinghoff joined LBT Innovations CEO…